Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Rabeprazole in the Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients

NCT00132496 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT00132496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00132496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Rabeprazole in the Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients
Lead sponsor
Eisai Inc.
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2005
Completion date
July 31, 2006
Enrollment
111 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease